LG rolls out new monitors targeted at mammography reads

LG Business Solutions USA is rolling out new monitors targeted at radiologists who specialize in breast imaging, the company recently announced. 

The new 21HQ613D-B monitor, which is approved by the U.S. Food and Drug Administration, is intended to improve the process of reading breast MRIs, mammograms and DBT exams. It is a 21.3-inch 5-megapixel (MP) monitor that offers high-definition detail of radiologic images. 

The new product’s internal front sensor eliminates the need for an external calibration device. DICOM calibration can be completed through LG’s Calibration Studio medical software, which also provides quality assurance tests to help maintain quality control standards for medical monitors.  

Additionally, its Focus View Mode and Multi-Resolution Mode allow for quick screen adjustments for individual images, and there are numerous other features intended to improve radiologists’ reading experience. 

"LG's new 5MP diagnostic monitor is tailored for reviewing mammograms and breast tomosynthesis, providing a high-quality medical imaging display with both simple management and practical features for users,” Stephen K. Hu, LG Business Solutions USA’s head of medical displays, said in a release. “We’re dedicated to providing cutting-edge solutions for the medical sector with our display technologies, and the addition of the latest 5MP monitor underscores this commitment to innovation.” 

The importance of diagnostic monitors is often overlooked until lapses in quality are uncovered via inspection. In one such case in Arizona recently, a radiology group’s use of “less technologically sophisticated” monitors had a whistleblower questioning the legitimacy of their Medicare claims of services. 

The whistleblower claimed that the company wrongfully billed CMS for millions of dollars in image reads that they believed disqualified the group for Medicare reimbursement due to the subpar computer monitors used to view the studies. They described the monitors, which were not considered medical grade, as “less technologically sophisticated” and, therefore, less effective. 

That case has not yet been resolved. 

To learn more about the new monitor, click here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.